VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,400,000 | +46.0% | 318,400 | 0.0% | 3.25% | +41.8% |
| Q1 2018 | $5,069,000 | -1.0% | 318,400 | +29.2% | 2.29% | -12.6% |
| Q4 2017 | $5,122,000 | +61.4% | 246,500 | +11.3% | 2.62% | +48.2% |
| Q3 2017 | $3,174,000 | -2.7% | 221,500 | +17.5% | 1.77% | -14.2% |
| Q2 2017 | $3,261,000 | +90.4% | 188,500 | +21.4% | 2.06% | +93.3% |
| Q1 2017 | $1,713,000 | -24.0% | 155,300 | 0.0% | 1.07% | -31.0% |
| Q4 2016 | $2,255,000 | -12.8% | 155,300 | +47.5% | 1.55% | -24.3% |
| Q3 2016 | $2,585,000 | +122.1% | 105,300 | +82.2% | 2.04% | +74.2% |
| Q2 2016 | $1,164,000 | -23.4% | 57,800 | 0.0% | 1.17% | -18.7% |
| Q1 2016 | $1,520,000 | -61.6% | 57,800 | +48.6% | 1.44% | -62.1% |
| Q4 2015 | $3,954,000 | – | 38,900 | – | 3.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |